Lilly mulls options as Medicare shuns Alzheimer's diagnostic

By Ransdell Pierson (Reuters) - Eli Lilly and Co on Monday said the federal government has unfairly blocked patient access to its Amyvid diagnostic test for Alzheimer's disease by denying reimbursement for such products, and said a requested new study of the test could create additional delay. "We are committed to this space and aren't letting this product go by the wayside," Eric Dozier, senior director of Lilly's Alzheimer's business division, said in an interview. The U.S. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/lilly-mulls-options-medicare-shuns-alzheimers-diagnostic-193259207--finance.html